Literature DB >> 14638375

Acute leukemia after infliximab therapy.

Guillermo Alcaín, Raúl J Andrade, María P Queipo de Llano, María J Moreno, Miren García-Cortés, Eduardo Franquelo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638375     DOI: 10.1111/j.1572-0241.2003.08682.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  TNF-alpha inhibitors and leukaemia: international pharmacovigilance reports.

Authors:  Ronald H B Meyboom; Kristina Star; Jenny Bate; Ruth Savage; I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 2.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

Review 3.  Acute promyelocytic leukaemia (APL) in a patient with Crohn's disease and exposure to infliximab: a rare clinical presentation and review of the literature.

Authors:  Farhan Mohammad; Abhirami Vivekanandarajah; Housam Haddad; Christopher M Shutty; Matthew T Hurford; Qun Dai
Journal:  BMJ Case Rep       Date:  2014-05-19

Review 4.  Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.

Authors:  Ashwin N Ananthakrishnan; Tamara Donaldson; Karen Lasch; Vijay Yajnik
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

Review 5.  Cancer risk in immune-mediated inflammatory diseases (IMID).

Authors:  Rudi Beyaert; Laurent Beaugerie; Gert Van Assche; Lieve Brochez; Jean-Christophe Renauld; Manuelle Viguier; Veronique Cocquyt; Guy Jerusalem; Jean-Pascal Machiels; Hans Prenen; Pierre Masson; Edouard Louis; Filip De Keyser
Journal:  Mol Cancer       Date:  2013-08-29       Impact factor: 27.401

6.  Acute Myeloid Leukemia with Myelodysplasia-Related Changes in a Patient with Crohn's Disease Treated with Immunosuppressive Therapy.

Authors:  Bowen Li; Zhenhua Zhu; Shunhua Long; Fei Li; Xuan Zhu; Wangdi Liao
Journal:  Case Rep Oncol       Date:  2018-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.